Startseite Hypomagnesemia due to two novel TRPM6 mutations
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Hypomagnesemia due to two novel TRPM6 mutations

  • Michelle Coulter EMAIL logo , Caroline Colvin , Bruce Korf , Ludwine Messiaen , Benjamin Tuanama , Michael Crowley , David K. Crossman und Kenneth McCormick
Veröffentlicht/Copyright: 30. Juli 2015

Abstract

Background: Although most hypocalcemia with hypomagenesemia in the neonatal period is due to transient neonatal hypoparathyroidism, magnesium channel defects should also be considered.

Case: We report a case of persistent hypomagnesemia in an 8-day-old Hispanic male who presented with generalized seizures. He was initially found to have hypomagnesemia, hypocalcemia, hyperphosphatemia and normal parathyroid hormone. Serum calcium normalized with administration of calcitriol and calcium carbonate. Serum magnesium improved with oral magnesium sulfate. However, 1 week after magnesium was discontinued, serum magnesium declined to 0.5 mg/dL. Magnesium supplementation was immediately restarted, and periodic seizure activity resolved after serum magnesium concentration was maintained above 0.9 mg/dL. The child was eventually weaned off oral calcium and calcitriol with persistent normocalemia. However, supraphysiologic oral magnesium doses were necessary to prevent seizures and maintain serum magnesium at the low limit of normal.

Methods and results: As his clinical presentation suggested primary renal magnesium wastage, TRPM6 gene mutations were suspected; subsequent genetic testing revealed the child to be compound heterozygous for TRPM6 mutations.

Conclusion: Two novel TRPM6 mutations are described with a new geographic and ethnic origin. This case highlights the importance of recognizing disorders of magnesium imbalance and describing new genetic mutations.


Corresponding author: Michelle Coulter, Division of Pediatric Endocrinology, University of Alabama at Birmingham, 1601 4th Ave South CPP 230, Birmingham, AL 35233, USA, Phone: +1(205) 638-9107, Fax: +1(205) 638-9821, E-mail:

References

1. Walder RY, Landau D, Meyer P, Shalev H, Tsolia M, et al. Mutations of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet 2002;31:171–4.10.1038/ng901Suche in Google Scholar PubMed

2. Schlingmann KP, Sassen MC, Weber S, Pechmann U, Kusch K, et al. Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemia. J Am Soc of Nephrol 2005;16:3061–9.10.1681/ASN.2004110989Suche in Google Scholar PubMed

3. Fawcett WJ, Haxby EJ, Male DA. Magnesium: physiology and pharmacology. Br J Anaesth 1999;83:972–3.10.1093/bja/83.2.302Suche in Google Scholar PubMed

4. Classen HG, Speich M, Schminatschek HF, Rattanatayarom W. Functional role of magnesium in vivo. In: Golf S, Dralle D, Vecchiet L, editors. Magnesium 1993. London: Libbey; 1994. p. 13–20.Suche in Google Scholar

5. Zofkoviu I, Kancheva RL. The relationship between magnesium and calciotropic hormones. Magnes Res 1995;8:77–84.Suche in Google Scholar

6. Anast CS, Winnacker JL, Forte LR, Burns TW. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976;42:707–17.10.1210/jcem-42-4-707Suche in Google Scholar PubMed

7. Rude RK, Oldham SB, Singer FR. Functional hypoparathyroidism and parathyroid hormone and organ resistance in human magnesium deficiency. Clin Endocrinol (Oxf) 1976;5:209–24.10.1111/j.1365-2265.1976.tb01947.xSuche in Google Scholar PubMed

8. Freitag JJ, Martin KJ, Conrades MB. Skeletal resistance to parathyroid hormone in magnesium deficiency: studies in isolated perfused bone. J Clin Invest 1979;64:1238–44.10.1172/JCI109578Suche in Google Scholar PubMed PubMed Central

9. Voets T, Nilius B, Hoefs S, van der Kemp AW, Droogmans G, et al. TRPM6 forms the Mg influx channel involved in intestinal and renal Mg absorption. J Biol Chem 2004;279:19–25.10.1074/jbc.M311201200Suche in Google Scholar PubMed

10. de Baaij JH, Hoenderop JG, Bindels RJ. Regulation of magnesium balance: lessons learned from human genetic disease. Clin Kidney J 2012;5:i15–24.10.1093/ndtplus/sfr164Suche in Google Scholar PubMed PubMed Central

11. Paunier L, Radde IC, Kooh SW, Conen PE, Fraser D. Primary hypomagnesemia with secondary hypocalcemia in an infant. Pediatrics 1968;41:385–402.Suche in Google Scholar

12. Walder RY, Shalev H, Brennan TM, Carmi R, Elbedour K, et al. Familial hypomagnesemia maps to chromosome 9q, not to the X chromosome: genetic linkage mapping and analysis of a balanced translocation breakpoint. Hum Mol Genet 1997;6:1491–7.10.1093/hmg/6.9.1491Suche in Google Scholar PubMed

13. Walder RY, Borochowitz Z, Shalev H, Carmi R, Elbedour K, et al. Hypomagnesemia with secondary hypocalcemia (HSH): narrowing the disease region on chromosome 9. Am J Hum Genet 1999;65:A51.Suche in Google Scholar

14. Schlingmann KP, Weber S, Peters M, Neimann Nejsum L, Vitzthum H, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet 2002;31:166–70.10.1038/ng889Suche in Google Scholar PubMed

15. Agus Z. Hypomagnesemia. J Amer Soc Nephrol 1999;10: 1616–22.10.1681/ASN.V1071616Suche in Google Scholar

16. Esteban-Oliva D, Pintos-Morell G, Konrad M. Long-term follow-up of a patient with primary hypomagnesaemia and secondary hypocalcaemia due to a novel TRPM6 mutation. Eur J of Pediatr 2009;168:439–42.10.1007/s00431-008-0767-1Suche in Google Scholar

17. Guran T, Akcay T, Bereket A, Atay Z, Turan S, et al. Clinical and molecular characterization of Turkish patients with familial hypomagnesaemia: novel mutations in TRPM6 and CLDN16 genes. Nephrol Dial Transplant 2012;27:667–73.10.1093/ndt/gfr300Suche in Google Scholar

18. Institute of Medicine (IOM): Food and Nutrition Board. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington, DC: National Academy Press, 1997.Suche in Google Scholar

19. Rodriguez-Soriano J, Vallo A, Garcia-Fuentes M. Hypomagnesemia of hereditary renal origin. Ped Nephrol 1987;1:465–72.10.1007/BF00849255Suche in Google Scholar

20. Rude RK, Bethune JE, Singer FR. Renal tubular maximimum for magnesium in normal, hyperparathyroid, and hypoaparthyroid man. J Clin Endocrinol Metab 1980;51:1425–31.10.1210/jcem-51-6-1425Suche in Google Scholar

21. Graber TW, Yee AS, Baker FJ. Magnesium: physiology, clinical disorders, and therapy. Ann Emerg Med 1981;10:49–57.10.1016/S0196-0644(81)80461-1Suche in Google Scholar

22. Moe, SM. Disorders involving calcium, phosphorous and magnesium. Prim Care 2008;35:215–37.10.1016/j.pop.2008.01.007Suche in Google Scholar PubMed PubMed Central

23. Thomas TC, Smith JM, White PC, Adhikari S. Transient neonatal hypocalcemia: presentation and outcomes. Pediatrics 2012;129:1461–67.10.1542/peds.2011-2659Suche in Google Scholar PubMed

24. Shah GM, Kirschenbaum MA. Renal magnesium wasting associated with therapeutic agents. Minter Electrolyte Metab 1991;17:58–61.Suche in Google Scholar

25. Hess MW, Hoenderop JG, Bindels RJ, Drenth JP. Systematic review: hypomagnesaemia induced by proton pump inhibition. Aliment Pharmacol Ther 2012;36:405–13.10.1111/j.1365-2036.2012.05201.xSuche in Google Scholar PubMed

26. Elisaf, M, Panteli K, Theodorou J, Siamopoulos KC. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res 1997;10:315–20.Suche in Google Scholar

Received: 2014-9-18
Accepted: 2015-6-15
Published Online: 2015-7-30
Published in Print: 2015-11-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Turner syndrome
  3. Turner syndrome – working together with patients and their families
  4. Turner syndrome patients with bicuspid aortic valves and renal malformations exhibit abnormal expression of X-linked inhibitor of apoptosis protein (XIAP)
  5. Inhibin B in adolescents and young adults with Turner syndrome
  6. Mode of initial presentation and chromosomal abnormalities in Irish patients with Turner syndrome: a single-centre experience
  7. Retrospective evaluation of pubertal development and linear growth of girls with Turner Syndrome treated with oral and transdermal estrogen
  8. Turner syndrome in Albania and the efficacy of its treatment with growth hormone
  9. Review articles
  10. The relation of vitamin D status with metabolic syndrome in childhood and adolescence: an update
  11. Putting the pieces together: cryptorchidism – do we know everything?
  12. Original articles
  13. Investigation of androgen receptor gene mutations in a series of 21 patients with 46,XY disorders of sex development
  14. Molecular diagnosis of maturity-onset diabetes of the young (MODY) in Turkish children by using targeted next-generation sequencing
  15. Association of physical activity level with depression, anxiety, and quality of life in children with type 1 diabetes mellitus
  16. Neonatal diabetes in Ukraine: incidence, genetics, clinical phenotype and treatment
  17. The effect of intraoperative administration of dexamethasone for PONV prophylaxis on perioperative blood glucose level in obese and normal weight children
  18. Are obesity and metabolic syndrome associated with plasma adropin levels in children?
  19. Carnitine insufficiency in children with inborn errors of metabolism: prevalence and treatment efficacy
  20. Comparison of energy expenditure, body composition, metabolic disorders, and energy intake between obese children with a history of craniopharyngioma and children with multifactorial obesity
  21. Effect of serum cholesterol on bone mineral density in normal-weight children and adolescents
  22. Assessment of bone turnover markers and bone mineral density in normal short boys
  23. Long-term treatment for hyperphenylalaninemia and phenylketonuria: a risk for nutritional vitamin B12 deficiency?
  24. Risk factors affecting the development of nephrocalcinosis, the most common complication of hypophosphatemic rickets
  25. Children with hyperthyroidism younger than age 7 require higher mg/kg doses of methimazole to normalize free T4 compared to older children
  26. Effects of bisphosphonates to treat osteoporosis in children with cerebral palsy: a meta-analysis
  27. AMH levels at central precocious puberty and premature thelarche: is it a parameter?
  28. Validating Paediatric Morphometrics: body proportion measurement using photogrammetric anthropometry
  29. Treatment of central precocious puberty and early puberty with GnRH analog in girls with Williams-Beuren syndrome
  30. Short communication
  31. Pilot study on the dietary habits and lifestyles of girls with idiopathic precocious puberty from the city of Rome: potential impact of exposure to flame retardant polybrominated diphenyl ethers
  32. Patient reports
  33. Hypomagnesemia due to two novel TRPM6 mutations
  34. A novel mutation of AMH in three siblings with persistent Mullerian duct syndrome
  35. Kocher-Debré-Semelaigne syndrome with rhabdomyolysis and increased creatinine
  36. Anaphylaxis to gonadorelin acetate in a girl with central precocious puberty
  37. Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemia
Heruntergeladen am 11.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0394/html?lang=de
Button zum nach oben scrollen